Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

N/ACompletedNCT02669771

Astellas Pharma Inc1,018 enrolled

Overview

The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.

Study Type

OBSERVATIONAL

Enrollment

1,018

oral

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * no history of treatment with enzalutamide Exclusion Criteria: \-

Unnamed facility

Incidences of Adverse Events

Time frame: Up to 2 years

Overall Survival

Time frame: Up to 2 years

Change from baseline in PSA value

PSA: prostate-specific antigen

Time frame: Up to 2 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.